Hall Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$470K Buy
4,308
+950
+28% +$110K 0.17% 69
2025
Q4
$353K Sell
3,358
-295
-8% -$27.7K 0.14% 74
2025
Q3
$307K Sell
3,653
-1,440
-28% -$119K 0.12% 83
2025
Q2
$403K Sell
5,093
-1,004
-16% -$79.8K 0.17% 68
2025
Q1
$547K Sell
6,097
-14,729
-71% -$1.38M 0.25% 59
2024
Q4
$2.07M Buy
+20,826
New +$2.15M 0.97% 37
2024
Q2
$2.91M Buy
23,529
+1,161
+5% +$150K 1.39% 25
2024
Q1
$2.95M Sell
22,368
-265
-1% -$32.7K 1.46% 25
2023
Q4
$2.47M Buy
22,633
+2,734
+14% +$284K 1.45% 28
2023
Q3
$2.05M Buy
19,899
+1,620
+9% +$175K 1.31% 30
2023
Q2
$2.11M Buy
18,279
+4,064
+29% +$461K 1.19% 32
2023
Q1
$1.51M Buy
14,215
+8,892
+167% +$960K 0.9% 39
2022
Q4
$591K Sell
5,323
-51
-0.9% -$5.21K 0.35% 53
2022
Q3
$463K Sell
5,374
-88
-2% -$7.86K 0.31% 63
2022
Q2
$498K Sell
5,462
-381
-7% -$33.8K 0.33% 63
2022
Q1
$479K Sell
5,843
-1,125
-16% -$88.7K 0.28% 70
2021
Q4
$534K Sell
6,968
-3,055
-30% -$243K 0.3% 64
2021
Q3
$753K Sell
10,023
-78
-0.8% -$5.93K 0.48% 50
2021
Q2
$786K Buy
+10,101
New +$751K 0.51% 49
2020
Q4
$876K Sell
11,225
-267
-2% -$20.4K 0.63% 42
2020
Q3
$910K Sell
11,492
-312
-3% -$24.4K 0.72% 41
2020
Q2
$871K Buy
11,804
+554
+5% +$41.7K 0.73% 42
2020
Q1
$826K Buy
11,250
+539
+5% +$42.4K 0.84% 40
2019
Q4
$930K Buy
10,711
+388
+4% +$31.9K 0.76% 45
2019
Q3
$829K Sell
10,323
-272
-3% -$21.8K 0.72% 45
2019
Q2
$848K Buy
10,595
+1,243
+13% +$95.2K 0.72% 47
2019
Q1
$742K Buy
9,352
+31
+0.3% +$2.32K 0.65% 48
2018
Q4
$680K Sell
9,321
-120
-1% -$8.47K 0.68% 46
2018
Q3
$639K Sell
9,441
-147
-2% -$9.37K 0.55% 50
2018
Q2
$555K Sell
9,588
-79
-0.8% -$4.46K 0.52% 53
2018
Q1
$502K Sell
9,667
-1,383
-13% -$74.7K 0.48% 56
2017
Q4
$593K Sell
11,050
-1,368
-11% -$75.8K 0.52% 53
2017
Q3
$759K Buy
12,418
+42
+0.3% +$2.55K 0.7% 46
2017
Q2
$757K Buy
12,376
+657
+6% +$40K 0.71% 45
2017
Q1
$711K Buy
11,719
+830
+8% +$50.4K 0.67% 48
2016
Q4
$611K Buy
+10,889
New +$637K 0.6% 49
2015
Q3
$222K Buy
4,724
+262
+6% +$13.9K 0.26% 71
2015
Q2
$242K Sell
4,462
-169
-4% -$9.48K 0.28% 71
2015
Q1
$254K Buy
4,631
+681
+17% +$38.6K 0.26% 76
2014
Q4
$214K Buy
+3,950
New +$220K 0.22% 81

Other funds holding MRK

Hall Capital Management's MRK Position: Q1 2026 in Review

Hall Capital Management increased its Merck (MRK) stake by 28% in Q1 2026, buying an estimated $110K and bringing the position to 4,308 shares worth $470K. The position accounts for 0.17% of the portfolio, ranked #69.

Hall Capital Management first reported a position in MRK in Q4 2014 and has held it in 40 quarters since. The position peaked at $2.95M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Hall Capital Management held 4,308 shares of Merck worth $470K as of Q1 2026.
  • Hall Capital Management bought 950 Merck shares in Q1 2026, an estimated $110K.
  • Merck made up 0.17% of Hall Capital Management's portfolio in Q1 2026, its #69 holding.
  • Hall Capital Management first reported a position in Merck in Q4 2014 and has held it in 40 quarters since.
  • Hall Capital Management's Merck position peaked at $2.95M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Hall Capital Management's 13F filing for Q1 2026, filed 11 May 2026.